Germantown, MD, United States of America

Yusuf U Vohra

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Yusuf U. Vohra**

Introduction

Yusuf U. Vohra, based in Germantown, MD, is a notable inventor recognized for his significant contributions in the field of pharmaceuticals. With a total of two patents to his name, Vohra's work primarily focuses on developing innovative compounds that can potentially aid in the treatment and prevention of various diseases.

Latest Patents

Vohra's latest patents include groundbreaking findings on "Galactopyranosyl-cyclohexyl derivatives as E-selectin antagonists." These patents present compounds, compositions, and methods aimed at inhibiting the binding of E-selectin to its ligands. The applications of these discoveries extend to developing pharmaceutical compositions that utilize E-selectin antagonists for treating or preventing medical conditions linked to E-selectin interactions.

Career Highlights

Yusuf U. Vohra has established a reputable career with Glycomimetics, Inc., where he plays a pivotal role in advancing therapeutic innovations. His dedication and expertise in creating viable pharmaceutical solutions exhibit his commitment to improving patient outcomes and contributing to the research community.

Collaborations

Throughout his career, Vohra has collaborated with esteemed colleagues, including John L. Magnani and John M. Peterson. Together, they work towards enhancing the understanding and application of glycomimetic strategies in medical science, showcasing the power of collaboration in fostering innovation.

Conclusion

In summary, Yusuf U. Vohra's contributions as an inventor are vital in the pursuit of new medical treatments. His innovative patents and collaborations with fellow researchers pave the way for advancements in pharmaceutical science, holding promise for future applications in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…